Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
Study Summary
This trial is testing whether using ultrasound to scan the lungs can help improve the accuracy of diagnosing heart failure in the ambulance, and whether this leads to earlier treatment.
Who is the study for?
This trial is for adults over 17 years old who are experiencing shortness of breath. It's not suitable for those with a high fever, pregnant women, patients with very low blood pressure, anyone showing certain heart attack signs on an EKG, or trauma patients.Check my eligibility
What is being tested?
The study is testing if using lung ultrasound (LUS) in ambulances helps to diagnose acute heart failure better than the usual care without LUS. The goal is to see if this leads to quicker and more accurate treatment.See study design
What are the potential side effects?
Since the intervention involves non-invasive lung ultrasound, there are minimal expected side effects compared to usual medical procedures; however, any discomfort or risks related to standard emergency care still apply.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Diagnostic accuracy of pre-hospital providers for identifying AHF versus not AHF
Secondary outcome measures
Rate of initiation of AHF therapies in patients with AHF
Timing of AHF therapies in patients with AHF
Trial Design
2Treatment groups
Experimental Treatment
Group I: Usual CareExperimental Treatment1 Intervention
Group II: Lung UltrasoundExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Lung Ultrasound
2016
N/A
~1770
Find a Location
Who is running the clinical trial?
Indiana UniversityLead Sponsor
980 Previous Clinical Trials
983,054 Total Patients Enrolled
17 Trials studying Heart Failure
3,692 Patients Enrolled for Heart Failure
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a fever higher than 100.4F.Adults over 17 years old who are experiencing shortness of breath as their main health concern.You have low blood pressure (SBP <90).You have a specific abnormality in your heart's electrical activity called ST-segment elevation on an EKG.People who have recently been injured are not eligible.
Research Study Groups:
This trial has the following groups:- Group 1: Usual Care
- Group 2: Lung Ultrasound
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
May new participants join this clinical experiment at the present time?
"In accordance with the information posted on clinicaltrials.gov, this specific trial is not currently enrolling patients. Although it was first published in October 1st 2022 and last updated on August 22nd of that same year, there are other 700 research studies actively looking for participants as we speak."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger